Want to join the conversation?
$PH said that for FY17 the company expects earnings from continuing operations in the range of $6.15-6.85 per share, or $6.40-7.10 per share on an adjusted basis. FY17 guidance is adjusted for expected business realignment expenses of approx. $0.25 per share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.